NCT00454831View on ClinicalTrials.gov

Efficacy and Safety of HEP-40 Chitosan for Mild to Moderately Elevated Cholesterol

PHASE2CompletedINTERVENTIONAL

Enrollment

207

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

September 30, 2007

Conditions

Hypercholesterolemia

Interventions

DEVICE

HEP-40 chitosan

Enzymatically Hydrolyzed Polychitosamine-40 kDa

Trial Locations (1)

H3Z 1R7

JSS Medical Research Inc., Westmount

Sponsors

Collaborators (1)

JSS Medical Research Inc.

All Listed Sponsors

collaborator

JSS Medical Research Inc.

INDUSTRY

lead

DNP Canada

INDUSTRY